Denosumab may reduce hypercalcaemia after transplantation for osteopetrosis

BMJ 2012; 345 doi: http://dx.doi.org/10.1136/bmj.e7477 (Published 7 November 2012)
Cite this as: BMJ 2012;345:e7477

Get access to this article and all of bmj.com for the next 14 days

Sign up for a 14 day free trial today

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

In osteopetrosis, defective osteoclasts impair bone resorption and excessive bone is formed. Haematopoietic stem cell transplantation is the only cure for this rare inherited disorder, but it is …

Get access to this article and all of bmj.com for the next 14 days

Sign up for a 14 day free trial today

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

Article access

Article access for 1 day

Purchase this article for £20 $30 €32*

The PDF version can be downloaded as your personal record

* Prices do not include VAT

THIS WEEK'S POLL